Loading financials from SEC filings…
· Fiscal year ends Dec 31
Net income was $340M. Operating cash flow of −$426M less capital expenditure of $89,000 left free cash flow of −$426M. Net debt was $2.2B.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Interest expense | 67.5 | 62.3 | 77.5 | 77.2 | 92.2 |
| Net income | 174 | 102 | 337 | 263 | 340 |
| Diluted EPS | 1.49 | 0.79 | 2.31 | 1.61 | 1.85 |
| Diluted shares | 116 | 127 | 145 | 162 | 189 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 133 | 14.6 | 98.1 | 42.7 | 57.0 |
| Total assets | 2,600 | 3,029 | 3,417 | 3,832 | 4,584 |
| Long-term debt | 1,236 | 1,574 | 1,555 | 1,769 | 2,286 |
| Total liabilities | 1,291 | 1,627 | 1,614 | 1,842 | 2,368 |
| Shareholders' equity | 1,309 | 1,401 | 1,803 | 1,990 | 2,216 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 129 | −425 | 68.3 | −118 | −426 |
| Capital expenditure | 0.1 | 0.1 | 0.9 | 0.7 | 0.1 |
| Free cash flow | 129 | −425 | 67.4 | −119 | −426 |
| Depreciation & amortisation | 0.3 | 0.2 | 0.2 | 0.5 | 0.3 |
| Stock-based compensation | 10.4 | 10.8 | 11.9 | 12.5 | 14.8 |
| Share buybacks | 2.8 | 4.5 | 12.7 | 3.4 | 6.5 |
| Dividends paid | 176 | 245 | 274 | 303 | 326 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| EPS growth (YoY) | – | −47.0% | 192.4% | −30.3% | 14.9% |
| Return on equityBlank when equity is negative | 13.3% | 7.3% | 18.7% | 13.2% | 15.3% |
| Cash conversion (CFO ÷ net income) | 0.74x | −4.16x | 0.20x | −0.45x | −1.25x |
| Debt ÷ equity | 0.94x | 1.12x | 0.86x | 0.89x | 1.03x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 1,103 | 1,560 | 1,457 | 1,726 | 2,229 |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.